HealthLupin launches first fixed-dose triple-combination inhaler for COPD in India
Lupin has launched Formoflo-G MDI, the world’s first fixed-dose triple-combination metered-dose inhaler for chronic obstructive pulmonary disease (COPD) in India. Approved by the Drug Controller General of India, it combines glycopyrronium bromide, formoterol fumarate, and fluticasone propionate for long-term management of moderate to severe COPD. Lupin aims to expand treatment options for over 55 million COPD patients in India and strengthen its respiratory medicines market position.
Business Standard·


